Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in

Pontifax Venture Capital

Status
ACTIVE
Global HQ
Herzliya, Israel
Countries of investment
  • Israel
  • USA
  • Canada
Investment stages
  • Seed
Industries
  • Health Tech
  • Biotechnology
  • AI
  • Data Science
About
Pontifax Venture Capital sources groundbreaking innovations in life sciences, invests in clinical stage companies, and provides hands-on guidance for success.
Min check size
$1M
Max check size
$20M
Fund size
NPS

Investment Thesis

Pontifax focuses on groundbreaking innovations in life sciences. They seek transformative healthcare technologies in all development stages.
Lead investor
Co Invest
Number of exits
Preferred contact method

Manager's Experience

Bringing extensive expertise in private equity, the fund manager has successfully executed over 50 deals across various sectors, including technology, healthcare, and consumer goods. Active primarily in North America and Europe, their strategic style emphasizes a data-driven approach that seeks to identify high-growth opportunities. Noteworthy exits include several multi-bagger returns, demonstrating a robust investment stage focus on growth and expansion. Their operator-first mindset facilitates deep collaboration with portfolio companies, driving operational improvements and value creation.

Pontifax Venture Capital Contacts Information

Primary contact

Secondary contact

Team

Ran Nussbaum

Ohad Hammer

Ben Shai

Asaf Shinar

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp